13 November

Antibody E-Conference 2020

We discussed the science behind the research program, the benefits of immunotherapy, and the progress of Pure Biologics R&D projects.

The event was attended by the representatives of the Company:

  • dr. Przemysław Jurek – Director of Research & Development in Pure Biologics
  • dr. Richard Fox – Director of Preclinical Development in Pure Biologics
  • dr. Filip Jeleń, MBA – Pure Biologics Founder, Chairman of the Board

and a special guest:

  • dr. hab. Radosław Zagożdżon – specialist in clinical immunology, physician and scientist at the Medical University of Warsaw, Pure Biologics scientific consultant.

Watch: 🎥 Video – Antibody E-Conference 2020 (🇵🇱)


Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers